| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -340.5% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 1.9 | n/a |
| Pr/Book | 1.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | -100.0% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-11 | 0.71 | (2.44) | (1.59)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| New Distribution Agreements & Sales Update | 14-May-2012 | 07:00 | RNS |
| Interim Results for 6 months ended 31 Dec 2011 | 21-Mar-2012 | 07:00 | RNS |
| Holding(s) in Company | 07-Mar-2012 | 17:34 | RNS |
| Losses to double at 3D Diagnostic | 12-May-2011 | ShareCast |
| 3D Diagnostic doubles losses | 07-Mar-2011 | ShareCast |
| 3D Diagnostic debuts on AIM | 22-Nov-2010 | ShareCast |
| Dental company 3D Diagnostic issues profit warning | 16-Dec-2011 | The Herald |
| 3D Diagnostics moves to boost sales as shares sl... | 16-Dec-2011 | The Scotsman |
| 3D losses double to £2.4m | 23-Sep-2011 | The Herald |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.53p |
| Change Today | -0.050p |
| % Change | -8.70 % |
| 52 Week High | 2.75p |
| 52 Week Low | 0.40p |
| Volume | 60,000 |
| Shares Issued | 240.97m |
| Market Cap | £1.27m |
| Beta | 0.50 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 09:13 | 60,000 @ 0.40p |
| CEO | Graham Robert Lay |
| CFO | Oliver Charles Cooke |
You are here: research